Here are the five richest physician billionaires (Note: Net worth is accurate as of Oct. 9):
Net worth: $30.7 billion
Dr. Frist co-founded HCA Healthcare alongside his father in 1968 and currently holds more than 20% ownership in the company. Although he no longer serves in an executive capacity, both of his sons now sit on the board of directors.
Net worth: $6 billion
Dr. Soon-Shiong developed pancreatic cancer drug Abraxane and later sold his companies — Abraxis in 2010 and American Pharmaceutical in 2008, for a total of $9.1 billion. In 2015, he took his cancer drug company NantKwest public, followed by his biotech startup NantHealth in 2016.
Net worth: $3.5 billion
Dr. Schleifer is the co-founder and CEO of Regeneron Pharmaceuticals, a biotechnology company he helped establish in 1988. He took the company public in 1991 and currently holds nearly 4% of its common stock. Regeneron, recognized for developing six FDA-approved drugs, is best known for Eylea, a treatment for macular degeneration.
Net worth: $2.7 billion
Dr. Troendle is the president, CEO and founder of clinical research company Medpace and owns about 24% of the stock. Before founding Medpace, Dr. Troendle spent five years as a director at Swiss pharma company Sandoz, now known as Novartis.
Net worth: $2.2 billion
Dr. Yancopoulos is the co-founder, president and chief scientific officer of Regeneron Pharmaceuticals. He owns about 1% of the stock. Regeneron was cofounded by Dr. Schleifer in 1988, and Dr. Yancopoulos joined the next year.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.